Lawrence S Olanoff insider trades: Ironwood Pharmaceuticals (IRWD) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Lawrence reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 10, 2020 | IRWD | ↓ Sell | 11,350 | $10.06 | $114K | Direct | Jun 12, 2020 (2d) |
| Jun 5, 2019 | IRWD | ↓ Sell | 2,000 | $11.25 | $23K | Direct | Jun 7, 2019 (2d) |
| Mar 5, 2019 | IRWD | ↓ Sell | 2,000 | $14.41 | $29K | Direct | Mar 6, 2019 (1d) |
| Dec 6, 2018 | IRWD | ↓ Sell | 2,000 | $12.47 | $25K | Direct | Dec 10, 2018 (4d) |
| Sep 5, 2018 | IRWD | ↓ Sell | 2,000 | $19.10 | $38K | Direct | Sep 7, 2018 (2d) |
| Jun 5, 2018 | IRWD | ↓ Sell | 2,000 | $17.62 | $35K | Direct | Jun 7, 2018 (2d) |
| Mar 5, 2018 | IRWD | ↓ Sell | 2,000 | $14.05 | $28K | Direct | Mar 6, 2018 (1d) |
| Dec 4, 2017 | IRWD | ↓ Sell | 2,000 | $16.46 | $33K | Direct | Dec 6, 2017 (2d) |
| Sep 5, 2017 | IRWD | ↓ Sell | 2,000 | $16.15 | $32K | Direct | Sep 7, 2017 (2d) |
| Jun 8, 2017 | IRWD | ↓ Sell | 3,200 | $17.78 | $57K | Direct | Jun 12, 2017 (4d) |
| Mar 3, 2017 | IRWD | ↓ Sell | 3,200 | $17.19 | $55K | Direct | Mar 7, 2017 (4d) |
| Dec 5, 2016 | IRWD | ↓ Sell | 3,200 | $15.68 | $50K | Direct | Dec 7, 2016 (2d) |
| Sep 6, 2016 | IRWD | ↓ Sell | 3,200 | $13.72 | $44K | Direct | Sep 7, 2016 (1d) |
| Jun 3, 2016 | IRWD | ↓ Sell | 2,200 | $12.92 | $28K | Direct | Jun 6, 2016 (3d) |
| Mar 7, 2016 | IRWD | ↓ Sell | 2,200 | $11.11 | $24K | Direct | Mar 9, 2016 (2d) |
| Dec 7, 2015 | IRWD | ↓ Sell | 2,200 | $11.77 | $26K | Direct | Dec 8, 2015 (1d) |
| Sep 4, 2015 | IRWD | ↓ Sell | 3,725 | $10.97 | $41K | Direct | Sep 9, 2015 (5d) |
| Aug 26, 2013 | FRX | ↓ Sell | 1,104 | $42.96 | $47K | Direct | Aug 27, 2013 (1d) |
| Mar 4, 2013 | FRX | ↓ Sell | 543 | $36.77 | $20K | Direct | Mar 4, 2013 (0d) |
| Sep 5, 2012 | FRX | ↓ Sell | 561 | $34.90 | $20K | Direct | Sep 6, 2012 (1d) |
| Mar 7, 2012 | FRX | ↓ Sell | 561 | $32.39 | $18K | Direct | Mar 9, 2012 (2d) |
| Nov 14, 2005 | CLN | ↑ Buy | 76,645 | $0.33 | $25K | Direct | Nov 15, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IRWD insiders
Open-market trades in the last 12 months
About Lawrence S Olanoff's insider trades
Lawrence S Olanoff is a director at Ironwood Pharmaceuticals (IRWD). Since Nov 14, 2005, Lawrence has reported 1 open-market purchase worth $25K and 21 sales worth $788K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (20 filings), shares withheld for taxes (8 filings), shares returned to the company (2 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IRWD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.